Symptoms of overdose include ventricular tachycardia, ventricular fibrillation, progressive bradyarrhythmias, or heart block.
Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis lanata.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Amiodarone | The serum concentration of Deslanoside can be increased when it is combined with Amiodarone. |
| Amphotericin B | The risk or severity of adverse effects can be increased when Amphotericin B is combined with Deslanoside. |
| Edrophonium | Edrophonium may increase the atrioventricular blocking (AV block) and arrhythmogenic activities of Deslanoside. |
| Itraconazole | The serum concentration of Deslanoside can be increased when it is combined with Itraconazole. |
| Kaolin | The serum concentration of Deslanoside can be decreased when it is combined with Kaolin. |
| Midodrine | Deslanoside may increase the bradycardic, atrioventricular blocking (AV block), and arrhythmogenic activities of Midodrine. |
| Propafenone | The serum concentration of Deslanoside can be increased when it is combined with Propafenone. |
| Quinine | The serum concentration of Deslanoside can be increased when it is combined with Quinine. |
| Quinidine | The serum concentration of Deslanoside can be increased when it is combined with Quinidine. |
| Reserpine | The risk or severity of adverse effects can be increased when Reserpine is combined with Deslanoside. |
| Telmisartan | The serum concentration of Deslanoside can be increased when it is combined with Telmisartan. |
| Tolevamer | The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Deslanoside. |
| Sulpiride | The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Deslanoside. |
| Parathyroid hormone | The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Deslanoside. |
| Calcitriol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcitriol is combined with Deslanoside. |
| Calcifediol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcifediol is combined with Deslanoside. |
| Ergocalciferol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Ergocalciferol is combined with Deslanoside. |
| Cholecalciferol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Cholecalciferol is combined with Deslanoside. |
| Paricalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Deslanoside. |
| Dihydrotachysterol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Dihydrotachysterol is combined with Deslanoside. |
| Alfacalcidol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Alfacalcidol is combined with Deslanoside. |
| Seocalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Seocalcitol is combined with Deslanoside. |
| Inecalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Inecalcitol is combined with Deslanoside. |
| Becocalcidiol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Becocalcidiol is combined with Deslanoside. |
| Eldecalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Eldecalcitol is combined with Deslanoside. |
| 1alpha,24S-Dihydroxyvitamin D2 | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when 1alpha,24S-Dihydroxyvitamin D2 is combined with Deslanoside. |
| Elocalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Elocalcitol is combined with Deslanoside. |
| Maxacalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Maxacalcitol is combined with Deslanoside. |
| Doxercalciferol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Doxercalciferol is combined with Deslanoside. |
| Vitamin D | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Vitamin D is combined with Deslanoside. |
| 1alpha-Hydroxyvitamin D5 | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when 1alpha-Hydroxyvitamin D5 is combined with Deslanoside. |
| Previtamin D(3) | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Previtamin D(3) is combined with Deslanoside. |
| Labetalol | Labetalol may increase the bradycardic activities of Deslanoside. |
| Pindolol | Pindolol may increase the bradycardic activities of Deslanoside. |
| Bevantolol | Bevantolol may increase the bradycardic activities of Deslanoside. |
| Penbutolol | Penbutolol may increase the bradycardic activities of Deslanoside. |
| Bufuralol | Bufuralol may increase the bradycardic activities of Deslanoside. |
| Bopindolol | Bopindolol may increase the bradycardic activities of Deslanoside. |
| Arotinolol | Arotinolol may increase the bradycardic activities of Deslanoside. |
| Levobetaxolol | Levobetaxolol may increase the bradycardic activities of Deslanoside. |
| Bucindolol | Bucindolol may increase the bradycardic activities of Deslanoside. |
| Esatenolol | Esatenolol may increase the bradycardic activities of Deslanoside. |
| Cloranolol | Cloranolol may increase the bradycardic activities of Deslanoside. |
| Mepindolol | Mepindolol may increase the bradycardic activities of Deslanoside. |
| Epanolol | Epanolol may increase the bradycardic activities of Deslanoside. |
| Erythromycin | The serum concentration of Deslanoside can be increased when it is combined with Erythromycin. |
| Azithromycin | The serum concentration of Deslanoside can be increased when it is combined with Azithromycin. |
| Sirolimus | The serum concentration of Deslanoside can be increased when it is combined with Sirolimus. |
| Dirithromycin | The serum concentration of Deslanoside can be increased when it is combined with Dirithromycin. |
| Telithromycin | The serum concentration of Deslanoside can be increased when it is combined with Telithromycin. |
| Candicidin | The serum concentration of Deslanoside can be increased when it is combined with Candicidin. |
| Clarithromycin | The serum concentration of Deslanoside can be increased when it is combined with Clarithromycin. |
| Josamycin | The serum concentration of Deslanoside can be increased when it is combined with Josamycin. |
| Everolimus | The serum concentration of Deslanoside can be increased when it is combined with Everolimus. |
| Epothilone D | The serum concentration of Deslanoside can be increased when it is combined with Epothilone D. |
| Patupilone | The serum concentration of Deslanoside can be increased when it is combined with Patupilone. |
| 6-Deoxyerythronolide B | The serum concentration of Deslanoside can be increased when it is combined with 6-Deoxyerythronolide B. |
| Ixabepilone | The serum concentration of Deslanoside can be increased when it is combined with Ixabepilone. |
| KOS-1584 | The serum concentration of Deslanoside can be increased when it is combined with KOS-1584. |
| Ridaforolimus | The serum concentration of Deslanoside can be increased when it is combined with Ridaforolimus. |
| Temsirolimus | The serum concentration of Deslanoside can be increased when it is combined with Temsirolimus. |
| AVE9633 | The serum concentration of Deslanoside can be increased when it is combined with AVE9633. |
| Coltuximab ravtansine | The serum concentration of Deslanoside can be increased when it is combined with Coltuximab ravtansine. |
| Cethromycin | The serum concentration of Deslanoside can be increased when it is combined with Cethromycin. |
| Mitemcinal | The serum concentration of Deslanoside can be increased when it is combined with Mitemcinal. |
| Brefeldin A | The serum concentration of Deslanoside can be increased when it is combined with Brefeldin A. |
| Solithromycin | The serum concentration of Deslanoside can be increased when it is combined with Solithromycin. |
| Kitasamycin | The serum concentration of Deslanoside can be increased when it is combined with Kitasamycin. |
| Carbomycin | The serum concentration of Deslanoside can be increased when it is combined with Carbomycin. |
| Doramectin | The serum concentration of Deslanoside can be increased when it is combined with Doramectin. |
| Eprinomectin | The serum concentration of Deslanoside can be increased when it is combined with Eprinomectin. |
| Oleandomycin | The serum concentration of Deslanoside can be increased when it is combined with Oleandomycin. |
| Selamectin | The serum concentration of Deslanoside can be increased when it is combined with Selamectin. |
| Tildipirosin | The serum concentration of Deslanoside can be increased when it is combined with Tildipirosin. |
| Tilmicosin | The serum concentration of Deslanoside can be increased when it is combined with Tilmicosin. |
| Tylosin | The serum concentration of Deslanoside can be increased when it is combined with Tylosin. |
| Tylvalosin | The serum concentration of Deslanoside can be increased when it is combined with Tylvalosin. |
| Bryostatin 1 | The serum concentration of Deslanoside can be increased when it is combined with Bryostatin 1. |
| Lorvotuzumab mertansine | The serum concentration of Deslanoside can be increased when it is combined with Lorvotuzumab mertansine. |
| Epofolate | The serum concentration of Deslanoside can be increased when it is combined with Epofolate. |
| Sagopilone | The serum concentration of Deslanoside can be increased when it is combined with Sagopilone. |
| Troleandomycin | The serum concentration of Deslanoside can be increased when it is combined with Troleandomycin. |
| Miocamycin | The serum concentration of Deslanoside can be increased when it is combined with Miocamycin. |
| Flurithromycin | The serum concentration of Deslanoside can be increased when it is combined with Flurithromycin. |
| Rokitamycin | The serum concentration of Deslanoside can be increased when it is combined with Rokitamycin. |
| Midecamycin | The serum concentration of Deslanoside can be increased when it is combined with Midecamycin. |
| Clindamycin | The serum concentration of Deslanoside can be increased when it is combined with Clindamycin. |
| Mepartricin | The serum concentration of Deslanoside can be increased when it is combined with Mepartricin. |
| Succinylcholine | The risk or severity of Cardiac Arrhythmia can be increased when Succinylcholine is combined with Deslanoside. |
| Metocurine iodide | The risk or severity of Cardiac Arrhythmia can be increased when Metocurine iodide is combined with Deslanoside. |
| Gallamine triethiodide | The risk or severity of Cardiac Arrhythmia can be increased when Gallamine triethiodide is combined with Deslanoside. |
| Cisatracurium | The risk or severity of Cardiac Arrhythmia can be increased when Cisatracurium is combined with Deslanoside. |
| Rocuronium | The risk or severity of Cardiac Arrhythmia can be increased when Rocuronium is combined with Deslanoside. |
| Atracurium besylate | The risk or severity of Cardiac Arrhythmia can be increased when Atracurium besylate is combined with Deslanoside. |
| Doxacurium | The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Deslanoside. |
| Tubocurarine | The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Deslanoside. |
| Mivacurium | The risk or severity of Cardiac Arrhythmia can be increased when Mivacurium is combined with Deslanoside. |
| Decamethonium | The risk or severity of Cardiac Arrhythmia can be increased when Decamethonium is combined with Deslanoside. |
| Metocurine | The risk or severity of Cardiac Arrhythmia can be increased when Metocurine is combined with Deslanoside. |
| Pancuronium | The risk or severity of Cardiac Arrhythmia can be increased when Pancuronium is combined with Deslanoside. |